PracticeLink Magazine

FALL 2017

The career development quarterly for physicians of all specialties, PracticeLink Magazine provides readers with feature articles, compensation stats, helpful job search tips—as well as recruitment ads from organizations across the U.S.

Issue link:

Contents of this Issue


Page 40 of 95   FALL 2017 41 T E C H N O T E S the morphine equivalency calculator and a subsection that explains how to perform motivational interviewing with chronic pain patients. I can't overemphasize the importance of the app's motivational interviewing section. It gives physicians the opportunity to use evidence-based techniques for behavior change. The techniques have been proven to reduce the risk of opioid misuse, increase patient motivation to change, and decrease depression in the setting of opioid use. This app is a must-have for primary care physicians and other physicians who prescribe opioid therapy on a daily basis. Key ways to use this app: If a patient presents with chronic pain, use the app to determine if their medication dosing should be changed, or if they are at risk for opioid addiction. Use the morphine equivalency calculator to determine conversions for opioid therapy. Use the motivational interviewing section with patients. It's a patient-centered approach to causing behavior to change. DAPT Risk Calculator: Help deciding on treatment The American College of Cardiology (ACC) is one of the most active medical societies in the mobile space. The DAPT Risk Calculator is one of their latest medical apps and continues the association's trend of producing useful and free medical apps. Duration of Dual Antiplatelet Therapy (DAPT) is a big deal for patients who undergo cardiac catheterization procedures. While the length of DAPT after bare metal stents and drug eluting stents is well established, guidelines aren't as clear on what to do after 12 months. Serious harm can arise from continuing antiplatelet therapy, such as gastrointestinal bleeds. The DA PT score, developed from the DA PT study randomized trial data, helps physicians determine whether or not anticoagulation therapy should be continued based on a patient's comorbidities and stenting characteristics. Though there are online calculators for this, having it available at the point of care provides ease of use and

Articles in this issue

Links on this page

Archives of this issue

view archives of PracticeLink Magazine - FALL 2017